Assembly Biosciences ASMB Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's short-term investments?
- Assembly Biosciences (ASMB) reported short-term investments of $195.48M in Q1 2026.
- How has Assembly Biosciences's short-term investments changed year-over-year?
- Assembly Biosciences's short-term investments increased by 189.1% year-over-year, from $67.62M to $195.48M.
- What is the long-term trend for Assembly Biosciences's short-term investments?
- Over 5 years (2020 to 2025), Assembly Biosciences's short-term investments has grown at a 3.9% compound annual growth rate (CAGR), from $156.97M to $189.66M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.